Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- J Natl Cancer Inst1
Search Results
Sort by
- Bookeditor, Stephanie J. Dancer.Contents:
Staphylococcus aureus antibiotic resistance / Stephanie J. Dancer
Understanding resistance mechanisms / Efthimia Petinaki & Iris Spiliopoulou
Staphylococcus aureus epidemiology and screening : best practice / Iris Spiliopoulou & Efthimia Petinaki
Methicillin-resistant Staphylococcus aureus : impact on care in the neonatal unit / Melissa U. Nelson, Matthew J. Bizzarro & Patrick G. Gallagher
Environmental cleaning : the effect of cleaning on MRSA transmission risk / Stephanie J. Dancer
Computational simulation modeling of Staphylococcus aureus outbreaks / Bruce Y. Lee & Leslie E. Mueller
Role of rapid diagnostics in selecting optimal therapy for Staphylococcus aureus infections / Richard A. Proctor & Drew Smith
Novel compounds for therapy : antibiotics and alternative therapies / Kimberly Hammer, Melissa A. Rohrich, Catherine Wieser & Tze Shien Lo
Multiple choice questions : answers. - ArticleKaledin VI, Kurunov YN, Matienko NA, Nikolin VP.J Natl Cancer Inst. 1978 Dec;61(6):1393-6.The growth of Krebs-2 carcinoma in BCG-prevaccinated virgin female C57BL/6, CC57BR/M, and C3Hf mice was studied in relation to the number of living mycobacteria in the organism. When the number of mycobacteria was high, tumor growth was stimulated. After the bacteria were eliminated, tumor growth was inhibited. The effect of BCG was based, on the one hand, on the diversion of effector cells, presumably macrophages, responsible for tumor defense and, on the other hand, on the activation of the pool of these cells. The conclusions were reached that high doses of BCG may be dangerous in human cancer immunotherapy and that patients predisposed to neoplastic disease should be revaccinated with BCG.